FRIDAY, June 6, 2025 (HealthDay News) — Attorneys general from four states are asking the U.S. Food and Drug Administration ...

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone​," but experts say concerns ...

THURSDAY, June 5, 2025 (HealthDay News) — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has ordered a fresh ...

Four states filed a petition urging federal health officials to ease regulations regarding the use of mifepristone, a pill ...

The attorneys general of New York, California, Massachusetts and New Jersey asked the FDA to lift some requirements on ...

The petition comes after the FDA commissioner said the agency would conduct a safety review of the medication.

Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, ...

The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill’s safety.

Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...

Four attorneys general filed a petition with the FDA to lift restrictions on the abortion medication mifepristone.

Officials in NJ and other states petitioned the FDA to waive restrictions for a long-prescribed abortion pill that they argue block access to the drug.

The petition urges the agency to do away with an “unnecessary” and “burdensome” regulatory framework that significantly ...